Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,024,468 papers from all fields of science
Search
Sign In
Create Free Account
Molindone Hydrochloride
Known as:
4H-Indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-, Monohydrochloride
, Lidone
, Hydrochloride, Molindone
Expand
The hydrochloride salt form of molindone, a dihydroindolone compound with antipsychotic and anti-schizophrenic properties not structurally related to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Adrenergic alpha-Antagonists [MoA]
Antipsychotic Agents
Comatose
Drug Allergy
Expand
Narrower (1)
Moban
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit/hyperactivity disorder and persistent, serious conduct problems.
Jennifer Dugan Stocks
,
B. K. Taneja
,
P. Baroldi
,
R. Findling
Journal of child and adolescent…
2012
Corpus ID: 26670248
OBJECTIVE To evaluate safety and tolerability of four doses of immediate-release molindone hydrochloride in children with…
Expand
2008
2008
Determination of molindone enantiomers in human plasma by high-performance liquid chromatography-tandem mass spectrometry using macrocyclic antibiotic chiral stationary phases.
Hongliang Jiang
,
Yinghe Li
,
+5 authors
Q. Ji
Journal of Chromatography A
2008
Corpus ID: 25843584
Review
1989
Review
1989
Molindone hydrochloride: a review of laboratory and clinical findings.
R. Owen
,
J. Cole
Journal of Clinical Psychopharmacology
1989
Corpus ID: 19344896
Molindone hydrochloride, a dihydroindolone neuroleptic, is structurally distinct from other classes of neuroleptics. Molindone…
Expand
Review
1985
Review
1985
Molindone hydrochloride treatment of hospitalized children with conduct disorder.
L. Greenhill
,
M. Solomon
,
R. Pleak
,
P. Ambrosini
Journal of Clinical Psychiatry
1985
Corpus ID: 19272561
Treatment-emergent symptoms and behavioral changes were assessed during an 8-week double-blind study comparing molindone and…
Expand
1985
1985
Bioavailability of oral and intramuscular molindone hydrochloride in schizophrenic patients.
M. Zetin
,
M. Cramer
,
+4 authors
W. Schary
Clinical Therapeutics
1985
Corpus ID: 20814041
This study was designed to assess the bioequivalence of intramuscular molindone hydrochloride and marketed oral molindone. Ten…
Expand
1985
1985
Clinical experience with molindone hydrochloride in geriatric patients.
M. Peper
Journal of Clinical Psychiatry
1985
Corpus ID: 28016706
Elderly patients (N = 28) with a variety of psychiatric disorders were treated with molindone in an 8-week open clinical trial…
Expand
1984
1984
Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro.
R. Abraham
,
J. Knapp
,
M. B. Minnigh
,
L. Wong
,
M. Zemaitis
,
J. Alvin
Drug Metabolism And Disposition
1984
Corpus ID: 33036084
The metabolism of furazolidone by rat liver and Escherichia coli was characterized in vitro under aerobic and anaerobic…
Expand
1981
1981
Molindone Hydrochloride in the treatment of aggressive, hospitalized children [proceedings].
L. Greenhill
,
J. E. Barmack
,
D. Spalten
,
M. Anderson
,
F. Halpern
Psychopharmacology bulletin
1981
Corpus ID: 46675126
1979
1979
Reuse of coated enzyme-linked immunosorbent assay plates.
M. Bar-joseph
,
M. Moscovitz
,
Yehudit Sharafi
1979
Corpus ID: 53531102
BAR-JOSEPH, M., M. MOSCOVITZ, and Y. SHARAFI. 1979. Reuse of coated enzyme-linked immunosorbent assay plates. Phytopathology 69…
Expand
1967
1967
Psychopharmacological Profile of Molindone
A. Rubin
,
H. C. Yen
,
M. Pfeffer
Nature
1967
Corpus ID: 4278417
RECENT clinical reports1–3 have indicated that the combination of a neuroleptic and an antidepressant affords an added measure of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE